Skip to main content

Oncology

Multiple Myeloma, Oncology
CAR T-Cell Immunotherapy Makes Strides in Multiple Myeloma, with Durable Remission
Wayne Kuznar
Read More
Immunotherapy, Oncology
Checkpoint Inhibitors Show Promise in Patients with Mesothelioma
Phoebe Starr
Read More
Immunotherapy, Oncology
Pembrolizumab Makes Inroads in Sarcoma Subtypes
Phoebe Starr
Read More
Leukemia, Oncology
In Chronic Myeloid Leukemia, Selection of Tyrosine Kinase Inhibitors Depends on Variables Other Than Survival
Wayne Kuznar
Read More
Leukemia, Oncology
ASCO 2017: Chronic Lymphocytic Leukemia Highlights
Read More
Multiple Myeloma, Oncology
ASCO 2017: Multiple Myeloma Highlights
Read More
Immunotherapy, Oncology
Adoptive T-Cell Therapy: Ready for Prime Time
Chase Doyle
Read More
Breast Cancer, Oncology
Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer
Lowell L Hart, MD
Read More
Breast Cancer, FDA Approvals, Oncology
Kisqali, a New CDK4/CDK6 Inhibitor, Approved as First-Line Therapy for HR-Positive, HER2-Negative Advanced Breast Cancer
Read More
Lung Cancer, Oncology
Smoking Cessation and Lung Cancer
Edward Garon, MD
Read More
Page 14 of 27
Results 131 - 140 of 262